Literature DB >> 17604058

New insights into the regulation of cAMP synthesis beyond GPCR/G protein activation: implications in cardiovascular regulation.

Ross D Feldman1, Robert Gros.   

Abstract

Regulation of intracellular concentrations of cyclic AMP is one of the most ubiquitous mechanisms for regulating cellular functions. Further, the manner in which cAMP production is regulated via G proteins at the level of adenylyl cyclase activation has been studied extensively. This review focuses instead on the recently identified mechanisms and roles for regulation of adenylyl cyclase functions beyond G protein activation. These mechanisms include: a) the coupling of particular isoforms of adenylyl cyclase to function within a single cell type b) regulation of membrane trafficking of higher order enzyme aggregates and c) raf kinase-dependent phosphorylation and sensitization of adenylyl cyclases--an important pathway for crosstalk between tyrosine kinase signaling cascades with regulation of cAMP-mediated responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604058     DOI: 10.1016/j.lfs.2007.05.015

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Cell adhesion receptor GPR133 couples to Gs protein.

Authors:  Jens Bohnekamp; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

Review 2.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

3.  Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway.

Authors:  Dong Fu; Yoshiyuki Wakabayashi; Jennifer Lippincott-Schwartz; Irwin M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma.

Authors:  Eugene Sokolov; David A Iannitti; Laura W Schrum; Iain H McKillop
Journal:  Cell Signal       Date:  2011-05-18       Impact factor: 4.315

5.  Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity.

Authors:  Jinying Chen; Zitai Sang; Lu Li; Linhong He; Liang Ma
Journal:  Mol Divers       Date:  2017-06-27       Impact factor: 2.943

6.  Suppression of adipose lipolysis by long-chain fatty acid analogs.

Authors:  Bella Kalderon; Narmen Azazmeh; Nili Azulay; Noam Vissler; Michael Valitsky; Jacob Bar-Tana
Journal:  J Lipid Res       Date:  2012-02-14       Impact factor: 5.922

Review 7.  Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment.

Authors:  Przemek A Gorski; Delaine K Ceholski; Roger J Hajjar
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

Review 8.  Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.

Authors:  W E Knight; C Yan
Journal:  Horm Metab Res       Date:  2012-09-05       Impact factor: 2.936

9.  Gating of the mitochondrial permeability transition pore by long chain fatty acyl analogs in vivo.

Authors:  Dmitri Samovski; Bella Kalderon; Einav Yehuda-Shnaidman; Jacob Bar-Tana
Journal:  J Biol Chem       Date:  2009-12-26       Impact factor: 5.157

10.  Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS.

Authors:  Carole Y Perrot; Junko Sawada; Masanobu Komatsu
Journal:  FASEB J       Date:  2018-05-18       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.